Jeff Hall

Senior Editor, Diagnostic Imaging

Articles by Jeff Hall

Can Multimodality AI Enhance CT Detection of Medium Vessel Occlusions?

The use of multiple artificial intelligence (AI) modalities to assess blood vessel density reduction and computed tomography perfusion (CTP) mismatch values facilitated a 93.3 percent detection rate for medium vessel occlusions, according to research presented recently at the International Stroke Conference.

New Research Assesses Key CT Signs for Predicting Bowel Necrosis

Demonstrating an 81 percent AUC, 99 percent specificity and a 98 percent positive predictive value, increased attenuation of intestinal contents was one of four CT findings deemed to be an independent predictive factor for bowel necrosis in patients with closed-loop small bowel obstruction.

MRI Study Reveals Significant Brain Changes in Adolescent Football Players

In contrast to high-school athletes from non-contact sports, adolescent football players had a variety of brain changes, including numerous areas of cortical thinning, increased sulcal depth and decreased coherence of neural signals in the frontal and medial regions, according to newly published magnetic resonance imaging (MRI) research.

Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?

In a recent interview, Markus Scherer, M.D., discussed emerging research, presented at the American College of Cardiology Cardiovascular Summit, which showed that coronary computed tomography angiography (CTA) was associated with a significantly higher likelihood of revascularization in comparison to other modalities or direct referral for invasive coronary angiography.

Study: 18F-Flotufolastat PET Imaging Changes Treatment in 89 Percent of Patients with Prostate Cancer Recurrence

For patients with recurrent prostate cancer, PET scanning with 18F-flotufolastat led to major changes in treatment for 80 percent of patients and 75 percent of patients with a changed treatment focus to watchful waiting had negative scans, according to new research presented at the American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium (ASCO-GU).

FDA Clears Updated AI Software for Lung CT

Reportedly offering improved delineation of pulmonary structures and greater accuracy with computed tomography (CT) values of pulmonary tissue, the artificial intelligence (AI)-powered LungQ 3.0.0. may facilitate enhanced precision and efficiency with interventional procedures such as lung volume reduction and ablation procedures.